1. Home
  2. COEP vs NTIP Comparison

COEP vs NTIP Comparison

Compare COEP & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • NTIP
  • Stock Information
  • Founded
  • COEP 2017
  • NTIP 1990
  • Country
  • COEP United States
  • NTIP United States
  • Employees
  • COEP N/A
  • NTIP N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • NTIP Multi-Sector Companies
  • Sector
  • COEP Health Care
  • NTIP Miscellaneous
  • Exchange
  • COEP Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • COEP 32.4M
  • NTIP 32.9M
  • IPO Year
  • COEP N/A
  • NTIP 1998
  • Fundamental
  • Price
  • COEP $13.17
  • NTIP $1.36
  • Analyst Decision
  • COEP
  • NTIP
  • Analyst Count
  • COEP 0
  • NTIP 0
  • Target Price
  • COEP N/A
  • NTIP N/A
  • AVG Volume (30 Days)
  • COEP 111.7K
  • NTIP 12.9K
  • Earning Date
  • COEP 03-25-2025
  • NTIP 03-07-2025
  • Dividend Yield
  • COEP N/A
  • NTIP 7.30%
  • EPS Growth
  • COEP N/A
  • NTIP N/A
  • EPS
  • COEP N/A
  • NTIP N/A
  • Revenue
  • COEP N/A
  • NTIP $1,881,000.00
  • Revenue This Year
  • COEP N/A
  • NTIP N/A
  • Revenue Next Year
  • COEP N/A
  • NTIP N/A
  • P/E Ratio
  • COEP N/A
  • NTIP N/A
  • Revenue Growth
  • COEP N/A
  • NTIP 129.39
  • 52 Week Low
  • COEP $2.31
  • NTIP $1.22
  • 52 Week High
  • COEP $13.70
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • COEP 66.28
  • NTIP 46.79
  • Support Level
  • COEP $8.65
  • NTIP $1.36
  • Resistance Level
  • COEP $12.95
  • NTIP $1.41
  • Average True Range (ATR)
  • COEP 1.60
  • NTIP 0.02
  • MACD
  • COEP -0.11
  • NTIP -0.00
  • Stochastic Oscillator
  • COEP 89.50
  • NTIP 20.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: